Pune, India, 2023 /MRFR Press Release/- Market research future has a half cooked research report on global pediatric brain tumor market. The Global Pediatric Brain Tumor Market is growing continuously and expected to grow at a CAGR of 6.8% from 2022 to 2030
The global pediatric brain tumor market has been evaluated as a steady growing market and it is expected to continue growing in the near future. The pediatric brain tumor market is growing at the CAGR of 6.8% during the forecast period and expected to reach USD 1843.7 Million by 2022-2030.
Increasing cases of pediatric brain tumors are leading the market growth. Various research initiatives taken by government, NGOs and healthcare providers are major driving forces of this market.
Taste the market data and market information presented through more than 56 market data tables and figures spread over 76 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Pediatric Brain Tumor Market Research Report –Global Forecast to 2030.”
Key companies to watch out for:
In 2016, Oncurious, Belgium based biotech startup launched a phase I/IIa trials for an antibody to fight pediatric brain tumors.
Canada based pharmaceutical company DelMar Pharmaceuticals, Inc. focused on research development and commercialization of new cancer therapies. In 2015, the company released a press note and claimed that their new chemotherapy treatment VAL-083 (dianhydrogalactitol) can be effective hemotherapeutic alternative for pediatric brain tumors.
Considering the global scenario of the pediatric brain tumor market, North America was holding the largest market share in global pediatric brain tumor market in 2016. Due to funding for R&D, high income and advanced healthcare, US is dominating North America market. European market is the second largest market for pediatric brain tumor. Increasing prevalence and awareness of disorder are key drivers for the growth of Asia Pacific pediatric brain tumor market. Middle East and Africa Pediatric brain tumor market is expected to limited growth it is mostly because of lack of knowledge of disorder and treatment, limited access to required healthcare facilities etc.
Global pediatric brain tumor market has been segmented on the basis of types which comprises of gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma/carcinoma, tumors arising from non-neuroepithelial tissue, meningeal tumors, and others. Gliomas is further sub-segmented into astrocytoma, malignant gliomas, and others. Mixed neuronal-glial tumors are further sub-segmented into ganglioglioma, subependymal giant cell tumor, pleomorphic xanthoastrocytoma, and others. Embryonal tumors are further sub-segmented into primitive neuroectodermal tumor (PNET), atypical teratoid/rhabdoid tumor, and others. Tumors arising from non-neuroepithelial tissue are further sub-segmented into craniopharyngioma, pineal region tumors, and others.
On the basis of diagnosis, it is segmented into physical exam, Imaging tests, brain or spinal cord tumor biopsy, lumbar puncture (spinal tap), blood and urine tests, and others. Imaging tests are further sub-segmented into Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan, Angiogram, and others. Magnetic Resonance Imaging (MRI) scan is further sub-segmented into Magnetic Resonance Angiography (MRA), Magnetic Resonance Spectroscopy (MRS), Magnetic Resonance Perfusion, Functional MRI (fMRI), and others. Brain or spinal cord tumor biopsy is further sub-segmented into stereotactic needle biopsy, craniotomy, and other.
On the basis of treatment, the market has been segmented into surgery, therapies, drug treatment, and others. Surgery is further sub-segmented into surgical biopsy, resection (removal), shunt placement/revision, and others. Therapies includes radiation therapy, chemotherapy, targeted therapy, and others. Chemotherapy includes carboplatin, carmustine (BCNU), cisplatin, cyclophosphamide, etoposide, lomustine (CCNU), methotrexate, temozolomide, thiotepa, vincristine, and others. Drug treatment is further sub-segmented into corticosteroids, anti-seizure drugs (anti-epileptics), hormones, and others.
On the basis of end user, it is segmented into hospitals and clinics, medical research centers, academic institutes, and others.
Explore In-depth Details: Pediatric Brain Tumor Market Research Report
Major Players in pediatric brain tumor market:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
+1 646 845 9312